Severe Asthma Exacerbation With a Deceptively Normal Blood Gas
A 29-year-old woman with asthma since childhood presents after 3 days of rhinorrhea and cough. She has used albuterol every 2 hours and is now speaking in single words. RR 34/min, HR 132/min, SpO2 86% on room air, peak expiratory flow 18% of predicted. Breath sounds are faint with minimal wheeze. She has received continuous nebulized albuterol/ipratropium, IV methylprednisolone 125 mg, and IV magnesium 2 g. Arterial blood gas on room air: pH 7.37, PaCO2 43 mm Hg, PaO2 54 mm Hg, HCO3 24 mEq/L. Chest radiograph is hyperinflated without infiltrate. She remains anxious but drowsy between nebulizers.
1. How do you interpret the arterial blood gas and clinical findings in this patient?
Read the worked answer
The key error is to call this blood gas "normal." In a tachypneic asthmatic, the expected compensatory response is hyperventilation with a low PaCO2, often 25–35 mm Hg. A PaCO2 of 43 mm Hg means she has lost that respiratory reserve and is tiring. The near-normal pH is also deceptive: it reflects a mixed picture of acute fatigue and only early renal compensation, not safety.
Clinical signs reinforce impending respiratory failure:
- Single-word dyspnea and RR 34/min indicate severe work of breathing.
- A faint chest with minimal wheeze suggests poor air movement, not improvement.
- Drowsiness between nebulizers is a red flag for hypercapnia and exhaustion.
- SpO2 86% and PaO2 54 mm Hg on room air show significant gas-exchange failure.
This is a life-threatening asthma exacerbation. The normal PaCO2 is a warning sign of fatigue, and observation alone would be dangerous.
2. What is the next best step: continue observation, start noninvasive ventilation, or proceed to endotracheal intubation? Explain your reasoning.
Read the worked answer
Proceed to endotracheal intubation with preparation for a difficult airway. The patient has clinical and gas-exchange evidence of impending respiratory arrest: exhaustion, drowsiness, poor air movement, hypoxemia, and a PaCO2 that is inappropriately normal rather than low.
Noninvasive ventilation is risky in severe asthma. Positive-pressure ventilation can worsen air trapping and barotrauma, and a trial of NIV may delay intubation in a patient who is already tiring. NIV is more defensible in COPD exacerbations or milder asthma with close monitoring, but this patient cannot protect her airway and is not improving despite maximal bronchodilators, steroids, and magnesium.
If there is any doubt, the safer course is to intubate in a controlled setting with anesthesia or critical care present, rather than wait for cardiovascular collapse. Delayed intubation in severe asthma is associated with worse outcomes.
3. What ventilator settings and pharmacologic adjuncts would you use immediately after intubation?
Read the worked answer
Use a strategy that minimizes dynamic hyperinflation and barotrauma:
- Low respiratory rate (10–12/min) to allow full exhalation.
- Tidal volume 6–8 mL/kg predicted body weight, with plateau pressure <30 cm H2O.
- High inspiratory flow (e.g., 60–80 L/min) and an I:E ratio of 1:4 or 1:5.
- Low PEEP (0–5 cm H2O) unless needed for oxygenation; high PEEP can worsen air trapping.
- Permissive hypercapnia targeting pH >7.20 rather than normalizing PaCO2.
- Monitor for auto-PEEP and disconnect briefly if hypotension develops.
Pharmacologically, continue inhaled albuterol/ipratropium, systemic corticosteroids, and consider magnesium. Ketamine is a reasonable induction agent because of its bronchodilator effect. Avoid excessive sedation that masks deterioration, and treat agitation cautiously because it may signal breath stacking.